Waiving intellectual property rights won’t raise vax production, says pharma body

| | New Delhi
  • 0

Waiving intellectual property rights won’t raise vax production, says pharma body

Tuesday, 11 May 2021 | PNS | New Delhi

The Organisation of Pharmaceutical Producers of India) on Monday said waiving intellectual property rights will not lead to increased production of Covid-19 vaccines, as it is not the barrier to their adequate availability in India. The industry body said it is cognizant that with the rising Covid-19 cases in India and other developing nations, there is an urgency to rapidly-produce greater quantities of Covid-19 vaccine. Vaccine manufacturing is a complex process and scaling up capacities involves the transfer of critical know-how, it added. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has already opposed the transfer of Intellectual Property (IP) waiver saying a waiver is the simple but the wrong answer to what is a complex problem.

State Editions

LG informs president Murmu of Atishi oath

19 September 2024 | Staff Reporter | Delhi

Delhi records 2,170 arms act cases in 2024

19 September 2024 | Staff Reporter | Delhi

North Delhi Medical College holds convocation ceremony

19 September 2024 | Staff Reporter | Delhi

Two cousins drowned in Yamuna during Ganpati immersion

19 September 2024 | Staff Reporter | Delhi

Sunday Edition

Paris Paralympics Para athletes bask in glory and gold

15 September 2024 | Rishabh Malik | Agenda

DUBLIN'S HIDDEN GEM

15 September 2024 | AKANKSHA DEAN | Agenda

From wheels to wings

15 September 2024 | Gyaneshwar Dayal | Agenda

We hope to instil a respect for our heritage:Tarun Thakral

15 September 2024 | Pioneer | Agenda

The Monsoon’s Whisper in Every Note

15 September 2024 | SAKSHI PRIYA | Agenda